CytoDyn Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CytoDyn Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • CytoDyn Inc. Debt-to-equity for the quarter ending August 31, 2024 was -113 %, a 3.05% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -113 -3.36 -3.05% Aug 31, 2024
Q2 2024 -109 +5.18 +4.53% May 31, 2024
Q1 2024 -109 +9.87 +8.28% Feb 29, 2024
Q4 2023 -111 +37.9 +25.5% Nov 30, 2023
Q3 2023 -110 +104 +48.6% Aug 31, 2023
Q2 2023 -114 +200 +63.6% May 31, 2023
Q1 2023 -119 +515 +81.2% Feb 28, 2023
Q4 2022 -149 +560 +79% Nov 30, 2022
Q3 2022 -214 +607 +73.9% Aug 31, 2022
Q2 2022 -315 +975 +75.6% May 31, 2022
Q1 2022 -634 +1.29K +67% Feb 28, 2022
Q4 2021 -708 +2.46K +77.7% Nov 30, 2021
Q3 2021 -821 +410 +33.3% Aug 31, 2021
Q2 2021 -1.29K -730 -130% May 31, 2021
Q1 2021 -1.92K -1.54K -399% Feb 28, 2021
Q4 2020 -3.17K -2.85K -897% Nov 30, 2020
Q3 2020 -1.23K -865 -236% Aug 31, 2020
Q2 2020 -560 -296 -112% May 31, 2020
Q1 2020 -385 -169 -78.2% Feb 29, 2020
Q4 2019 -318 -130 -69.5% Nov 30, 2019
Q3 2019 -367 -213 -138% Aug 31, 2019
Q2 2019 -264 -103 -63.6% May 31, 2019
Q1 2019 -216 -18.8 -9.54% Feb 28, 2019
Q4 2018 -188 +123 +39.6% Nov 30, 2018
Q3 2018 -154 -3.4K -105% Aug 31, 2018
Q2 2018 -162 -361 -181% May 31, 2018
Q1 2018 -197 -293 -304% Feb 28, 2018
Q4 2017 -310 -372 -605% Nov 30, 2017
Q3 2017 3.25K +3.17K +4107% Aug 31, 2017
Q2 2017 200 -42.9 -17.7% May 31, 2017
Q1 2017 96.4 +555 Feb 28, 2017
Q4 2016 61.4 +254 Nov 30, 2016
Q3 2016 77.2 +270 Aug 31, 2016
Q2 2016 243 +476 May 31, 2016
Q1 2016 -459 +2.74K +85.7% Feb 29, 2016
Q4 2015 -193 -410 -189% Nov 30, 2015
Q3 2015 -193 -278 -326% Aug 31, 2015
Q2 2015 -234 -324 -360% May 31, 2015
Q1 2015 -3.2K -3.32K -2933% Feb 28, 2015
Q4 2014 217 +10.6 +5.13% Nov 30, 2014
Q3 2014 85.4 +3.56K Aug 31, 2014
Q2 2014 90 +494 May 31, 2014
Q1 2014 113 +350 Feb 28, 2014
Q4 2013 207 +397 Nov 30, 2013
Q3 2013 -3.47K -3.34K -2550% Aug 31, 2013
Q2 2013 -404 -271 -205% May 31, 2013
Q1 2013 -237 -102 -75.3% Feb 28, 2013
Q4 2012 -191 Nov 30, 2012
Q3 2012 -131 Aug 31, 2012
Q2 2012 -132 May 31, 2012
Q1 2012 -135 Feb 29, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.